Journal of Endocrinology and Metabolism · 2013 · Clinical trial
Explore the library
Limited human evidenceModified growth-hormone fragment
AOD-9604
AOD-9604 is a modified peptide derived from the C-terminal region of human growth hormone. It was investigated in metabolic research and is distinct from full-length growth hormone.
Also indexed as: Lipolytic fragment hGH 177-191
A clear starting point
AOD-9604 is a modified peptide derived from the C-terminal region of human growth hormone. It was investigated in metabolic research and is distinct from full-length growth hormone.
Systems mapping shows biological relevance, not a treatment recommendation or a patient CPI score.
No validated chemical structure is displayed in this edition.
How it works
GH fragment / lipid metabolism
AOD-9604 is a modified peptide derived from the C-terminal region of human growth hormone. It was investigated in metabolic research and is distinct from full-length growth hormone.
- Targets & processes
- GH fragment / lipid metabolism
- Systems & tissues
- See the pathway description; category links describe research relevance, not demonstrated treatment effects.
What does the evidence show?
Whether a GH-derived fragment can influence lipid metabolism without reproducing all GH effects.
What this does not establish
Human safety research does not establish meaningful or durable weight-loss efficacy; no FDA-approved obesity indication.
Citation metadata from PubMed, a service of the U.S. National Library of Medicine, NIH. A citation match is not a guarantee of study quality. Abstracts are not full-text reviews.
Safety is a separate question
FDA identifies immunogenicity and impurity concerns and limited safety information; serious adverse events have been reported without clear causality.
Contraindications & cautions
Not an exhaustive contraindication review. FDA identifies immunogenicity and impurity concerns and limited safety information; serious adverse events have been reported without clear causality.
Medication & supplement interactions
Interaction information is incomplete. FDA identifies immunogenicity and impurity concerns and limited safety information; serious adverse events have been reported without clear causality.
Regulatory status · United States
Not FDA-approved. No FDA-approved finished drug for this molecule is identified in this edition. Investigational use, published research or compounding does not establish FDA approval.
Read the official sourceThis is not an exhaustive safety list. Regulatory status varies by jurisdiction and product; investigational use is not approval.
Make the science interactive
A dedicated lesson has not been published for this ingredient yet. Explore the cited profile or ask the instructor.
Your scientific classroom
Ask the IW Science Instructor
Basic level · Published sources only · AI evidence check
Ask about general science. Do not enter names, personal health details or medication lists. This is not a clinical consultation. Discussion stays in this browser’s private learning session for up to 90 days.
All medications and therapies discussed are for educational purposes only. Prescriptions are determined independently by the licensed clinician following a medical evaluation. There is no guarantee that any medication or peptide will be prescribed.
IW Interactive Learning Engine · Adapted from stable OpenMAIC v1.2.1. Open-source license
Education only. Confidence labels are not formal systematic evidence grades. No patient record is used.
Education only. Confidence labels are not formal systematic evidence grades. No patient record is used.